论文部分内容阅读
观察８１例原发性高脂血症患者用不同剂量血脂康的治疗效果，随机分为２组，Ａ组（３９例）服血脂康２粒／次，早晚各１次（１．２ｇ／ｄ），Ｂ组（４２例）服血脂康３粒／ｄ，每晚１次（０．９ｇ／ｄ），疗程均为８周。结果显示服血脂康后两组各血脂水平与治疗前比较，ＴＣ、ＴＧ、ＬＤＬＣ、（ＴＣ－ＨＤＬＣ）／ＨＤＬＣ均明显下降（Ｐ＜０．０１～＜０．００１），ＨＤＬＣ明显上升（Ｐ＜０．０１）；不同剂量血脂康降ＴＣ、ＴＧ、ＬＤＬＣ、（ＴＣ－ＨＤＬＣ）／ＨＤＬＣ，升ＨＤＬＣ的幅度无明显差异（Ｐ均＞０．０５）。提示每晚服３粒血脂康可获得较好的降脂疗效。
81 patients with primary hyperlipidemia treated with different doses of Xuezhikang were randomly divided into two groups, group A (39 cases) served Xuezhikang 2 tablets / time, sooner or later each time (1.2g / d ), Group B (42 cases) took Xuezhikang 3 tablets / d, once a night (0.9g / d) for 8 weeks. The results showed that the levels of TC, TG, LDLC, (TC-HDLC) / HDLC were significantly decreased (P0.01 ~ <0.001) , HDL-C significantly increased (P <0.01); different doses of Xuezhikang TC, TG, LDL C, (TC-HDL C) / HDL C, HDL C amplitude was no significant difference (P All> 0.05). Tip 3 serving per night Xuezhikang lipid-lowering effect can be better.